ArticleMedicine2019

HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b.

Zhijuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.